APT Medical Inc.

Shanghai Stock Exchange 688617.SS

APT Medical Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 30.46%

APT Medical Inc. Return on Capital Employed (ROCE) is 30.46% for the year ending December 31, 2023, a 37.60% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

APT Medical Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 22.13%, a 81.59% change year over year.
APT Medical Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 12.19%, a -52.30% change year over year.
APT Medical Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 25.55%, a 29.10% change year over year.
APT Medical Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 19.79%, a 112.97% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shanghai Stock Exchange: 688617.SS

APT Medical Inc.

CEO	Mr. Zhenghui Cheng
IPO Date	Jan. 7, 2021
Location	China
Headquarters	601, Building B
Employees	2,155
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Biotechnology Clinical Trials Hardware & Electronics Pharmaceuticals Robotics

Description

APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.

Key trends

Past 5 years